Kala Bio, Virotek sign LOI with US DNA testing platform to resell genomic tests

Bitget2026/09/24 11:31

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Kala Bio signed a non-binding LOI with a U.S. DNA testing platform to resell selected Virotek genomic testing products.
Commercial structure remains under negotiation; parties expect to name the resellers in coming weeks if talks conclude.
Move builds on the Sept. 3, 2026 exclusive U.S. distribution and reseller agreement with Virotek.
Kala would earn a profit-split or commission if the deal closes, with Virotek handling lab operations and order fulfillment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kala Bio Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609240730PRIMZONEFULLFEED9833075) on September 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Kala Bio, Virotek sign LOI with US DNA testing platform to resell genomic tests

You may also like

Crypto prices